Medpace Holdings, Inc. (MEDP)
NASDAQ: MEDP · Real-Time Price · USD
543.57
+13.98 (2.64%)
Jul 1, 2026, 4:00 PM EDT - Market closed
Medpace Holdings Employees
Medpace Holdings had 6,200 employees as of December 31, 2025. The number of employees increased by 300 or 5.08% compared to the previous year.
Employees
6,200
Change (1Y)
300
Growth (1Y)
5.08%
Revenue / Employee
$431,979
Profits / Employee
$74,258
Market Cap
15.52B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 6,200 | 300 | 5.08% |
| Dec 31, 2024 | 5,900 | 0 | - |
| Dec 31, 2023 | 5,900 | 700 | 13.46% |
| Dec 31, 2022 | 5,200 | 700 | 15.56% |
| Dec 31, 2021 | 4,500 | 900 | 25.00% |
| Dec 31, 2020 | 3,600 | 100 | 2.86% |
| Dec 31, 2019 | 3,500 | 600 | 20.69% |
| Dec 31, 2018 | 2,900 | 400 | 16.00% |
| Dec 31, 2017 | 2,500 | 0 | - |
| Dec 31, 2016 | 2,500 | 300 | 13.64% |
| Dec 31, 2015 | 2,200 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| IQVIA Holdings | 93,000 |
| Labcorp Holdings | 71,000 |
| Quest Diagnostics | 57,000 |
| ICON Public Limited Company | 40,100 |
| Charles River Laboratories International | 19,700 |
| Mettler-Toledo International | 18,100 |
| Revvity | 11,000 |
| Illumina | 10,080 |
MEDP News
- 15 days ago - Medpace Holdings, Inc. to Report Second Quarter 2026 Financial Results on July 22, 2026 - Business Wire
- 6 weeks ago - MEDP Fraud Notice: Medpace Sued for Securities Fraud after 16% Stock Drop -- Investors Reminded to Contact BFA Law by June 8 Case Deadline - GlobeNewsWire
- 7 weeks ago - Medpace Lawsuit Reminder: Investors with Losses after Company Discloses Cancellation Rates are Urged to Contact BFA Law before June 8 Deadline - NASDAQ:MEDP - GlobeNewsWire
- 7 weeks ago - MEDP Fraud News: Medpace Sued for Securities Fraud Over Cancellation Rates and 16% Stock Drop – Contact BFA Law if You Lost Money - Business Wire
- 2 months ago - Medpace price target lowered to $400 from $460 at BMO Capital - TheFly
- 2 months ago - Medpace price target lowered to $484 from $522 at RBC Capital - TheFly
- 2 months ago - Medpace price target lowered to $477 from $565 at Baird - TheFly
- 2 months ago - Medpace price target lowered to $450 from $500 at Barclays - TheFly